PTHS
Pelthos Therapeutics Inc.
NYSE MKT: PTHS · HEALTHCARE · BIOTECHNOLOGY
$25.09
+0.48% today
Updated 2026-04-29
Market cap
$83.79M
P/E ratio
—
P/S ratio
4.99x
EPS (TTM)
$-23.04
Dividend yield
—
52W range
$9 – $38
Volume
0.0M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+2.0
Profitability
F4.7
Valuation
C—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$57.14
+127.74%
12-Month target
—
—
Intrinsic (DCF)
$21.47
Margin of safety
-2.75%
1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at -257.90%
- Negative free cash flow $-6.35M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $16.80M | $16.80M |
| Net income | $-2.46M | $-7.38M | $-7.96M | $-43.32M | $-21.66M |
| EPS | — | — | — | — | $-23.04 |
| Free cash flow | $-1.57M | $-981031.00 | $-5.79M | $-22.69M | $-6.35M |
| Profit margin | — | — | — | -257.93% | -257.90% |
Peer comparison
Smart narrative
Pelthos Therapeutics Inc. trades at $25.09. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $16.80M. with profit margins at -257.90%. Our DCF model estimates intrinsic value at $21.47.
Frequently asked questions
What is Pelthos Therapeutics Inc.'s stock price?
Pelthos Therapeutics Inc. (PTHS) trades at $25.09.
Is Pelthos Therapeutics Inc. overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell). DCF value $21.47.
What is the price target of Pelthos Therapeutics Inc. (PTHS)?
The analyst target price is $57.14, representing +127.7% upside from the current price of $25.09.
What is the intrinsic value of Pelthos Therapeutics Inc. (PTHS)?
Based on our DCF model, intrinsic value is $21.47, a -2.8% margin of safety versus $25.09.
What is Pelthos Therapeutics Inc.'s revenue?
TTM revenue is $16.80M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio4.99x
ROE-239.60%
Beta3.99
50D MA$22.90
200D MA$25.64
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—